Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GONADORELIN: 225 Adverse Event Reports & Safety Profile

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More
225
Total FAERS Reports
12 (5.3%)
Deaths Reported
86
Hospitalizations
225
As Primary/Secondary Suspect
12
Life-Threatening
3
Disabilities
Oct 10, 1989
FDA Approved
Discontinued
Status

FDA Application: 018123 ·

First Report: 20050101 · Latest Report: 20250727

What Are the Most Common GONADORELIN Side Effects?

#1 Most Reported
Ovarian hyperstimulation syndrome
32 reports (14.2%)
#2 Most Reported
Neutropenia
31 reports (13.8%)
#3 Most Reported
Metastases to bone
24 reports (10.7%)

All GONADORELIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Ovarian hyperstimulation syndrome 32 14.2% 0 21
Neutropenia 31 13.8% 0 0
Metastases to bone 24 10.7% 0 3
Headache 20 8.9% 0 6
Malignant neoplasm progression 20 8.9% 0 4
White blood cell count decreased 20 8.9% 0 0
Carcinoembryonic antigen increased 15 6.7% 0 0
Breast cancer 14 6.2% 0 0
Nausea 14 6.2% 0 9
Central nervous system lesion 13 5.8% 0 6
Neutrophil count decreased 13 5.8% 0 1
Fatigue 10 4.4% 0 4
Product use in unapproved indication 10 4.4% 0 1
Rash 10 4.4% 0 4
Recalled product administered 10 4.4% 0 1
Alanine aminotransferase increased 9 4.0% 0 3
Ascites 9 4.0% 0 7
Aspartate aminotransferase increased 9 4.0% 0 3
Constipation 9 4.0% 0 3
Drug ineffective 9 4.0% 1 1

Who Reports GONADORELIN Side Effects? Age & Gender Data

Gender: 66.9% female, 33.1% male. Average age: 49.6 years. Most reports from: FR. View detailed demographics →

Is GONADORELIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2005 1 0 1
2009 1 0 0
2011 1 0 1
2012 1 0 0
2013 9 0 1
2014 9 0 1
2015 4 0 2
2016 14 0 12
2017 17 2 12
2018 14 0 6
2019 15 2 4
2020 22 1 14
2021 14 0 5
2022 21 0 6
2023 7 0 2
2024 4 0 2
2025 9 1 7

View full timeline →

What Is GONADORELIN Used For?

IndicationReports
Product used for unknown indication 45
Breast cancer 26
Prostate cancer metastatic 25
In vitro fertilisation 22
Breast cancer metastatic 15
Assisted reproductive technology 14
Prostate cancer 13
Ovulation induction 9
Controlled ovarian stimulation 5
Hormone replacement therapy 5

GONADORELIN vs Alternatives: Which Is Safer?

GONADORELIN vs GONADOTROPHIN, CHORIONIC GONADORELIN vs GOSERELIN GONADORELIN vs GRAMICIDIN GONADORELIN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B GONADORELIN vs GRAMICIDIN\POLYMYXIN B GONADORELIN vs GRANISETRON GONADORELIN vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS GONADORELIN vs GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GONADORELIN vs GRAZOPREVIR GONADORELIN vs GRISEOFULVIN

Official FDA Label for GONADORELIN

Official prescribing information from the FDA-approved drug label.